Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose

BACKGROUND: Coronavirus disease 2109 (COVID-19) vaccines have recently been approved to curb the global pandemic. The risk of allergic reactions to the vaccine polyethylene glycol (PEG) component has raised significant public concern. Desensitization is suggested in cases of vaccine related hypersen...

Descripción completa

Detalles Bibliográficos
Autores principales: AlMuhizi, Faisal, Ton-Leclerc, Shaonie, Fein, Michael, Tsoukas, Christos, Garvey, Lene Heise, Lee, Derek, Ben-Shoshan, Moshe, Isabwe, Ghislaine A. C., Copaescu, Ana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974752/
https://www.ncbi.nlm.nih.gov/pubmed/35386647
http://dx.doi.org/10.3389/falgy.2022.825164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974752/
https://www.ncbi.nlm.nih.gov/pubmed/35386647
http://dx.doi.org/10.3389/falgy.2022.825164

Ejemplares similares